Skip to main content

Drug Interactions between Levaquin and MTE-5

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

selenium levoFLOXacin

Applies to: MTE-5 (chromic chloride hexahydrate / copper sulfate / manganese sulfate / selenium / zinc sulfate) and Levaquin (levofloxacin)

LevoFLOXacin and selenium should not be taken orally at the same time. Products that contain magnesium, aluminum, calcium, iron, and/or other minerals may interfere with the absorption of levoFLOXacin into the bloodstream and reduce its effectiveness. If possible, it may be best to avoid taking selenium while you are being treated with levoFLOXacin. Otherwise, levoFLOXacin should be taken 2 to 4 hours before or 4 to 6 hours after a selenium dose, levoFLOXacin should be taken at least 2 hours before and not less than 6 hours after Suprep Bowel Prep (magnesium/potassium/sodium sulfates), or levoFLOXacin and selenium should be taken as directed by your healthcare provider. Talk to your healthcare provider if you are unsure whether your medications contain something that could potentially interact or if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Moderate

zinc sulfate levoFLOXacin

Applies to: MTE-5 (chromic chloride hexahydrate / copper sulfate / manganese sulfate / selenium / zinc sulfate) and Levaquin (levofloxacin)

LevoFLOXacin and zinc sulfate should not be taken orally at the same time. Products that contain magnesium, aluminum, calcium, iron, and/or other minerals may interfere with the absorption of levoFLOXacin into the bloodstream and reduce its effectiveness. If possible, it may be best to avoid taking zinc sulfate while you are being treated with levoFLOXacin. Otherwise, levoFLOXacin should be taken 2 to 4 hours before or 4 to 6 hours after a zinc sulfate dose, levoFLOXacin should be taken at least 2 hours before and not less than 6 hours after Suprep Bowel Prep (magnesium/potassium/sodium sulfates), or levoFLOXacin and zinc sulfate should be taken as directed by your healthcare provider. Talk to your healthcare provider if you are unsure whether your medications contain something that could potentially interact or if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

Moderate

levoFLOXacin food

Applies to: Levaquin (levofloxacin)

When levoFLOXacin as the oral solution is given with enteral (tube) feedings, levoFLOXacin may not work as well. You could interrupt the feeding for 1 hour before and 2 hours after the levoFLOXacin dose. However, this still may not entirely avoid the interaction and may not always be feasible. LevoFLOXacin oral tablets may be taken without regard to food. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.